Olympus Her
Olympus Her

Description
Female sexual desire is primarily neurological. Unlike male arousal — which is heavily vascular — women's desire originates in the brain, specifically in hypothalamic pathways that regulate motivation, reward, and emotional safety. This is why Bremelanotide, which activates those exact pathways, was FDA-approved for women and not for men.
Olympus Her pairs Bremelanotide with Oxytocin — the bonding hormone released naturally during intimacy, touch, and orgasm. Women have naturally higher baseline Oxytocin sensitivity than men, meaning the 20IU dose in this formula produces a pronounced effect: reduced anxiety, heightened emotional receptivity, and significantly enhanced orgasm intensity.
There is no Tadalafil in this formula. For women who want the addition of genital blood flow support, Olympus Her+ adds Tadalafil 5mg — the clinically validated female dose. Olympus Her is the pure desire-and-connection formula.
- FDA-approved for premenopausal women with HSDD
- Activates hypothalamic melanocortin receptors (MC3R/MC4R)
- Generates genuine neurological desire — not just physical arousal
- Effective in women unresponsive to hormonal therapy
- Works regardless of hormonal status or relationship duration
- Onset: 30–45 minutes; duration: several hours
- Women have 3x higher baseline Oxytocin sensitivity than men
- Amplifies emotional receptivity and trust
- Reduces performance anxiety and emotional barriers to intimacy
- Significantly enhances orgasm intensity
- Promotes post-intimacy bonding and connection
- Released naturally during touch, intimacy, and orgasm
| Specification | Detail |
|---|---|
| Product Name | Olympus Her |
| SKU | OLY-HER-001 |
| Active Ingredients | Oxytocin 20IU / Bremelanotide 1mg |
| Dosage Form | Sublingual / Buccal Flex-Dose Tablet |
| Quantity per Fill | 12 tablets |
| Refills Available | 3 |
| Target Patient | Women — premenopausal, HSDD, low desire |
| Compounding Pharmacy | Strive Pharmacy |
| Prescription Required | Yes |
⚠ State Telehealth Requirement
If you reside in one of the following states, state law requires a synchronous (live video) consultation with a licensed provider before a prescription can be issued:
Alaska • Arkansas • Delaware • Hawaii • Kansas • Maine • Mississippi • Missouri • Oregon • Rhode Island • West Virginia
To complete your consultation, please submit a brief video to your doctor so they can conduct the required synchronous review and finalize your prescription. Our clinical team will contact you with next steps after you place your order.